Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I tend to agree. AMRN was supposed to be much higher than it is at today. I think will meet its potential in the hands of a BP can make it actually happen
Waiting for 5 years and many here much longer. Its not like we are in a hurry
Interesting post of Stocktwits. Would be more meaningful after expanded label “ Oct 21st, 3:54 pm
$AMRN if a lot of pharma a and biotechs are getting acquired and their shareholders are benefiting because of this BOs it would be real unfair to us.
As we are under a CEO who thinks that he will do wonders in GIA and increase shareholder value.
Yes maybe in 10 years time when Amrn gets to 35 dollars by then.
Whereas the other companies shareholders are seeing their money right away due to their astute CEOs we have someone who is sputtering popcorn at the mouth
How many years do we have to wait JT?”
I dont know but I went on a diet in April and have lost 20-25lbs Vascepa for sure helped as it was the easiest 25 lbs I ever took off
JL- I arrived in Fla today. Will look forward to seeing you after we get squared away here with living arrangements in Deltona Orange City. Should be an interesting Nov-Dec to say the least.
There will be no BO until label is finalized. There's little chance of no from adcom, or yes adcom and no from FDA. Yes is likely but one can make good case for label to cover anywhere from 5 to 19 million patients/year which makes company impossible to value now: JMO
I paid $120 today for 3 months supply as I have met my yearly deductible and they actually had it in stock for the first time
JL - yes I agree. Vascepa on top of statin therapy is the smart move for now. Why antagonize BP any further?
Need an articulate dynamic communicator. JT is a bean counter and he sounds like one. I want JT to sell this thing to the highest bidder after label expansion. Tired of shenanigans. Endless
Youre right. Yesterday was the perfect example of why it will take years for AMRN to do what BP could do in months. Once Adcom is over snd approval comes I will be shocked if BP doesnt make an offer that shareholders CANT refuse. Otherwise- shenanigans will be never ending. Look at the past year. PPS going nowhere be ing played like a fiddle. I
Right on Tke45&. If the street knew what we do or even bothered to do DD this baby would be $35 poised to sky rocket in Nov-Dec. I know what I have with V. As far as Im concerned its a Godsend to humanity. How quickly will the world know that ??
Great post agree completely. Once we finally get approval those BPs who have do e their homework will be all over AMRN like white on rice. Its too good to pass up. This is the greatest drug of the 21st century as we all know.
There is no way I want or need a statin. There has to be millions like me. My Dr wrote me an off label script. Statins arent needed was my point
What about the millions of people NOT on statins like me- they all will have to get scripts off label. What V has done for me is amazing My cholesterol level is 145 including an LDL of 75. Why would I EVER need a statin??
Why do you feel that way?? Hope you're right
No Im just asking a question. AMRN long going on 5 years
Question. If BP makes an offer to buy AMRN for a dirt cheap $35/share, isn't the JT and BOD
obligated to take it due to the 100%+ premium? Because if they don't and nothing really changes after the adcom then the shareholder lawsuits will flood everyone's computer screens.
So this is actually the ideal time for BP to purchase Amarin for cheap. Even further, BP could also put in a breakup fee to Amarin and then if the adcom goes poorly, they just cancel the deal and pay the fee. It's a smooth move where BP can buy AMRN for little risk. Thoughts??
Does anybody here believe the FDA will make an announcement on Dec 28th smack dab between Christmas and New Years Day??? Why would they need an additional 6 weeks after ADCOM?? What are they doing now regarding AMRN ? What a frustrating load of crap. Meanwhile people die that could be saved. Big bloated inefficient government- a case study!
Every time JT gives one of the boilerplate PRs — the PPS tanks. If he ever mentioned a BO offer- it would shoot straight up.
The answer is no- even if its wrong to do so!
JL- what if BP makes an an offer even you couldnt refuse?? EVERY company is for sale. We win either way because V is the greatest drug in our lifetimes
You are correct Sir! BP just isnt going to sit back and watch multiple $Billions enrich another company that they could easily BO
So youre saying there is a chance we could hear something about an expanded label from the FDA in just 3 weeks???
I agree- that is why I havent given up on Sept 28th until we hear explicitly from the FDA. They could grant a limited expansion and still hold an ADCOM. We can dream cant we?? Maybe they are feeling pressure from medical community. ? Who knows?
As soon as we get expanded label- sell this baby JT- shenanigans are not going to stop. I will take my chances with the acquiring BP stock
Ok thank you.
Yes no doubt. BP would sell the bejabbers out of V like the ones you listed and many others. V is actually bigger than any of them Too many limiting factors with AMRN
I dont know but I am now! By the way—-
When Prostate Drug was approved the PPS jumped from 12 to 150 USD.
It extends life by 2 to 5%. I forgot- who was the BP - anyone ?
The V extends life by 25% ...
Pathetic for sure but what’s your guess ?? Short of a legit BO offer I think the shorts will still be around to take down the PPS after label expansion
Hey we can dream cant we???one of these days these predictions will come true. V is that good and we all know it- soon the world will also know it!!
Yes I would agree but after approval and a legit BO offer- a $45 PPS might be peanuts
Poster on Yahoo today. Pretty well thought out. Surely hope he is correct ————
“Approaching catalysts (some binary) & impact on stock price
So I’ll go out on a limb and provide input on catalysts and the corresponding pps movements. Some of this data is my own, while others I credit to inv bankers and BP staffers that I know personally. Just for fun I’m outlining what I expect (very conservative by nature) and you’ll see how I get my eoy pps.
Catalyst and PPS move
Citi fireside chat/tomorrow =. +/- .20. (Non event)
HC Wainwright/later in sept= same as citi (no real pps effect)
Pdufa appearing in FR, makes 11/14 adcom official=. -.50 drop
ICER final draft/late sept= + $1 to $1.50 jump
Evaporate whispers of data/late sept=$1 to $2 jump
Q3 revenue ATH and cash flow positive , +earnings =$1 to $1.50 jump
Adcom topic overview/mid Oct=-$1 to -$2 drop (sell off overblown)
Evaporate data release/early Nov=+$2 to +$3 jump (moa identified)
Adcom question better identified/nov 12=$3 to $5 swing (if it’s just label jump/if negative connotation then drop)
D Day11/14 win or lose=$12 to $15 jump on unanimous vote of approval OR $8 to $10 sell off on ambush
AHA 11/16 in Philadelphia momentum building w AHA SOC coming......Shock and awe effect 7 to 10 trading days w adcom news either another $5 jump or walk down into single digits on pps
Goldman and Chase initiating coverage/early Dec=+$2 to $3 jump
Fda rules for wide label, sNDA win 12/28=$1 to $3 jump
So in summary $17 to $19 pps by end of September. October tumultuous adcom topics will cause sell off, likely last chance for shorts then close oct sideways to September. JT pushing hard for evaporate the moa before adcom runs $20 to $22 into mid November. Adcom while filled w angst and uncertainty will be a shining moment $34 to $38 after and week or so into December trends pps to $40 floor. Chase and Goldman look like runners w their 2020 price targets and by eoy closing out at $43 to $44 pps
In 2020 this goes bananas. If fda has hidden agenda and out to ambush then it’ll be lucky to close $8 pps eoy. But, I can’t see an ambush. With Europe , ESC, EAS, ADA, ACC, AHA, NEJM there’s going to be many more reports, KOLs speaking up, surround sound so it’ll be a heck of a few months but eoy should close out beautifully with 2020 catalysts being incredible
Sitting on 12/31/19 @ $43.50 pps
Just wait for 2020 w billions in rev projected, hockey stick growth, 60 minutes spot and buyout war getting hot and heavy
It all boils down to 11/14, Amarin’s most important day ever either I’m wrong, fda ambush, close $8pps eoy OR I’m right wide and broad label, Wall St joins the Vascepa party and it’s off to the races”
I agree. He is better off the cuff. I think he realizes most of the shareholders are ticked off at the current PPS
I would take it if it were a stock deal
For you GIA folks- get real. I hope JT is on the phone with BP and ready to sell after label expansion. If he doesnt care about the PPS- he is being very negligent in his duties
Does JT care that the PPS is a big time concern for us - the shareholders??? I hope so otherwise we will get hosed
Lets hope JT does because even after label expansion there will be shenanigans by the shorts.
I hope youre right but I think ADCOM is not good for AMRN. So does Wall St. one year after R-I and the PPS going nowhere
I hope you guys are right. Im skeptical of the FDA. — they could blow this whole thing up
Wow- what a story- was concerned about you. Hope to see you in a couple months and hope to play golf wit h you again Best wishes!